Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HVIDOVRE FYSIOTERAPI OG RYGSKOLE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   11.3% 6.6% 4.2% 3.1% 4.2% 4.0% 18.2% 18.2%   Credit score (0-100)   23 37 48 54 48 48 8 8   Credit rating   BB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,202 1,862 2,365 2,943 2,599 3,326 0.0 0.0   EBITDA   155 282 261 359 132 268 0.0 0.0   EBIT   56.3 249 224 286 67.3 181 0.0 0.0   Pre-tax profit (PTP)   29.4 231.7 220.5 284.5 58.0 167.1 0.0 0.0   Net earnings   15.5 169.9 162.8 213.3 40.7 122.1 0.0 0.0   Pre-tax profit without non-rec. items   29.4 232 221 285 58.0 167 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   62.2 59.4 412 339 470 501 0.0 0.0   Shareholders equity total   -23.4 146 288 388 314 319 71.6 71.6   Interest-bearing liabilities   156 48.8 62.2 0.0 201 185 0.0 0.0   Balance sheet total (assets)   444 467 1,054 904 889 908 71.6 71.6   Net Debt   152 2.8 -2.5 -88.8 195 180 -71.6 -71.6     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,202 1,862 2,365 2,943 2,599 3,326 0.0 0.0   Gross profit growth   -12.3% -15.4% 27.0% 24.5% -11.7% 28.0% -100.0% 0.0%   Employees   0 0 0 0 0 5 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   444 467 1,054 904 889 908 72 72   Balance sheet change%   -25.7% 5.2% 125.7% -14.2% -1.7% 2.1% -92.1% 0.0%   Added value   155.3 281.6 261.5 358.8 139.6 267.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -198 -36 315 -145 67 -56 -501 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   2.6% 13.4% 9.5% 9.7% 2.6% 5.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.2% 53.3% 29.5% 29.3% 7.5% 20.1% 0.0% 0.0%   ROI %   28.6% 136.1% 72.8% 70.7% 14.2% 33.4% 0.0% 0.0%   ROE %   3.0% 57.6% 75.0% 63.1% 11.6% 38.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -5.0% 31.4% 27.3% 42.9% 35.3% 35.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   98.0% 1.0% -1.0% -24.7% 148.0% 67.1% 0.0% 0.0%   Gearing %   -666.9% 33.3% 21.6% 0.0% 63.9% 58.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   13.7% 16.7% 6.2% 6.3% 9.2% 7.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 1.0 0.8 0.9 0.6 0.6 0.0 0.0   Current Ratio   0.6 1.0 0.8 0.9 0.6 0.6 0.0 0.0   Cash and cash equivalent   3.7 46.0 64.7 88.8 5.9 5.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -189.3 -2.3 -171.8 -38.5 -233.0 -247.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 54 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 54 0 0   EBIT / employee   0 0 0 0 0 36 0 0   Net earnings / employee   0 0 0 0 0 24 0 0